| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 46 |
| 1 | MACITENTAN | 43 |
| 2 | SILDENAFIL CITRATE | 38 |
| 3 | SILDENAFIL | 30 |
| 4 | FUROSEMIDE | 27 |
| 5 | SILDENAFIL POWDER, | 25 |
| 6 | TADALAFIL | 24 |
| 7 | SELEXIPAG | 23 |
| 8 | WARFARIN | 15 |
| 9 | AMBRISENTAN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIVIBART | 1 | 0.0233 |
| 1 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 2 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 4 | ILOPROST | 1 | 0.0011 |
| 5 | BOSENTAN | 46 | 0.0009 |
| 6 | SELEXIPAG | 23 | 0.0009 |
| 7 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 8 | SILDENAFIL POWDER, | 25 | 0.0007 |
| 9 | MACITENTAN | 43 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 56 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 48 |
| 2 | Loop Diuretic [EPC] | 29 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 23 |
| 4 | Prostacycline Vasodilator [EPC] | 21 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 6 | Aldosterone Antagonist [EPC] | 15 |
| 7 | Corticosteroid [EPC] | 13 |
| 8 | Estrogen [EPC] | 13 |
| 9 | Factor Xa Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 23 | 0.0009 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 48 | 0.0004 |
| 3 | Endothelin Receptor Antagonist [EPC] | 56 | 0.0003 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 4 | 0.0003 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 8 | 0.0002 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 7 | Prostacycline Vasodilator [EPC] | 21 | 0.0002 |
| 8 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 9 | Chloride Channel Activator [EPC] | 1 | 0.0001 |